AbbVie · 18 hours ago
Senior Scientist I / II, Biologics Analytical R&D
North Chicago, IL
Full-time
Onsite
Mid, Senior Level
4+ years expAbbVie is dedicated to discovering and delivering innovative medicines to address serious health issues. The Senior Scientist I / II will focus on the development and implementation of analytical assays for complex biologics, contributing to the advancement of AbbVie's pharmaceutical products through analytical strategy and method development.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Effectively function as a scientist, generating original technical ideas and research or development strategies
Develop and optimize early-stage analytical methods using HPLC/UHPLC, CE-SDS and other separation/biophysical techniques
Drive the development of automated workflows for liquid handling platforms to improve method robustness and throughput
Author CMC analytical sections of IND/IMPD filings and contribute to global regulatory strategy alongside Reg Affairs
Collaborate daily with DS, DP, QA, late-stage stakeholders, and external CROs to align on method readiness and data packages
Demonstrate the ability to resolve key project hurdles and assumptions by effectively utilizing available information and technical expertise
Independently responsible for project science within his/her area of expertise on one or more project teams leading the method development and validation for complex biologic therapeutics
Proactively seek out new information in the literature and incorporate this into individual projects as well as the overall program
Qualification
Required
Ph.D degree in Biochemistry, Analytical Chemistry, Pharmaceutical Sciences or a closely related discipline or MS degree with 8 years of experience
Qualification for Senior Scientist I: Ph.D. with 0-4 years of industry experience is required with relevant experience or MS with 8 years of experience
Qualification for Senior Scientist II: Ph.D. with 4+ years of industry experience is required with relevant experience or MS with 10 years of experience
Hands-on expertise with HPLC/UPLC and CE-SDS, plus working familiarity with Hamilton or Tecan liquid-handling platforms
Working knowledge of cGMP expectations for early clinical materials; routine QC execution is not expected
Experience applying chemometrics / multivariate data analysis (e.g., PCA, MVM) and statistics to model-based method development
Demonstrated record of independent thought, creativity and scientific accomplishment (e.g. peer reviewed journal publications, patents)
Must have a solid understanding of protein/oligonucleotide chemistry and biochemistry, particularly as related to biologics drug development
Strong data and time organization/management skills coupled with strong interpersonal and effective communication skills for facilitating collaborations with a demonstrated ability to lead cross functional process development teams
Demonstrated scientific curiosity, creativity and comfort operating in ambiguity—key to inventing from scratch
Effective writer and communication of research or other regulatory materials
Preferred
Experience with analytical Multivariate Analytical Procedures development and/or validation a plus
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-02-04
2026-02-04
San Diego Union-Tribune
2026-02-04
Company data provided by crunchbase